Gilles Divita
Chief Executive & Scientific Officer Aanastra Inc
Seminars
Thursday 4th June 2026
Panel Discussion: Exploring Next-Generation Nanoparticle Systems Beyond LNPs to Expand Extrahepatic Targeting, Improve Safety, & Enable Broader Therapeutic Delivery
9:30 am
- Where do LNPs begin to show limitations for extrahepatic delivery and which emerging delivery vehicles offer the most realistic advantages?
- How do alternative delivery platforms compare in terms of manufacturability, scalability, safety, and regulatory readiness when moving towards the clinic?
- Which delivery challenges, from immunogenicity to targeting specificity, are best addressed by exploring non-LNP platforms, and where do LNPs remain the most practical solution?
Thursday 4th June 2026
Overcoming Hepatic Accumulation Using a Redosable Targeted Peptide-Based Nanoparticle Platform
11:00 am
- AI-driven design and optimization of a peptide-based targeted RNA delivery system
- PEP-NPTM: Highly selective, best-in-class, peptide nanoparticles for extrahepatic mRNA delivery
- In vivo mRNA based CAR-T cell engineering using novel targeted peptide-based nanoparticles
